PLPei-Yu Lin
Pei-Yu Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pei-Yu Lin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ana Ciurea
Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
1 shared publication - Cameron E. West
Department of Dermatology and Pathology, Texas Tech University, Abilene, TX 79601, USA
1 shared publication - Courtney Queen
Public Health, Texas Tech University Health Sciences Center , Abilene
1 shared publication - George Zouridakis
Department of Engineering Technology, University of Houston, Sugar Land, TX 77479, USA
1 shared publication - Neville Mathew
Department of Engineering Technology, University of Houston, Sugar Land, TX 77479, USA
1 shared publication - Renjie Hu
University of Houston
1 shared publication
Latest Publications
- Open Access
- 20 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 245
Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks
Melanoma is the most lethal form of skin cancer, and early detection is critical for improving patient outcomes. Although dermoscopy combined with deep learning has advanced automated skin-lesion analysis, progress is hindered by limited access to large, well-annotated datasets and by severe class imbalance, where melanoma images are substantially underrepresented. To address these challenges, we present the first systematic benchmarking study comparing four GAN architectures—DCGAN, StyleGAN2, and two StyleGAN3 variants (T and R)—for high-resolution () melanoma-specific synthesis. We train and optimize all models on two expert-annotated benchmarks (ISIC 2018 and ISIC 2020) under unified preprocessing and hyperparameter exploration, with particular attention to R1 regularization tuning. Image quality is assessed through a multi-faceted protocol combining distribution-level metrics (FID), sample-level representativeness (FMD), qualitative dermoscopic inspection, downstream classification with a frozen EfficientNet-based melanoma detector, and independent evaluation by two board-certified dermatologists. StyleGAN2 achieves the best balance of quantitative performance and perceptual quality, attaining FID scores of 24.8 (ISIC 2018) and 7.96 (ISIC 2020) at . The frozen classifier recognizes 83% of StyleGAN2-generated images as melanoma, while dermatologists distinguish synthetic from real images at only 66.5% accuracy (chance = 50%), with low inter-rater agreement (). In a controlled augmentation experiment, adding synthetic melanoma images to address class imbalance improved melanoma detection AUC from 0.925 to 0.945 on a held-out real-image test set. These findings demonstrate that StyleGAN2-generated melanoma images preserve diagnostically relevant features and can provide a measurable benefit for mitigating class imbalance in melanoma-focused machine learning pipelines.- 20 February 2026
- Published by MDPI AG in Bioengineering
- Vol. 13 (2) , 245
Open AccessSynthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks
Melanoma is the most lethal form of skin cancer, and early detection is critical for improving patient outcomes. Although dermoscopy combined with deep learning has advanced automated skin-lesion analysis, progress is hindered by limited access to large, well-annotated datasets and by severe class imbalance, where melanoma images are substantially underrepresented. To address these challenges, we present the first systematic benchmarking study comparing four GAN architectures—DCGAN, StyleGAN2, and two StyleGAN3 variants (T and R)—for high-resolution () melanoma-specific synthesis. We train and optimize all models on two expert-annotated benchmarks (ISIC 2018 and ISIC 2020) under unified preprocessing and hyperparameter exploration, with particular attention to R1 regularization tuning. Image quality is assessed through a multi-faceted protocol combining distribution-level metrics (FID), sample-level representativeness (FMD), qualitative dermoscopic inspection, downstream classification with a frozen EfficientNet-based melanoma detector, and independent evaluation by two board-certified dermatologists. StyleGAN2 achieves the best balance of quantitative performance and perceptual quality, attaining FID scores of 24.8 (ISIC 2018) and 7.96 (ISIC 2020) at . The frozen classifier recognizes 83% of StyleGAN2-generated images as melanoma, while dermatologists distinguish synthetic from real images at only 66.5% accuracy (chance = 50%), with low inter-rater agreement (). In a controlled augmentation experiment, adding synthetic melanoma images to address class imbalance improved melanoma detection AUC from 0.925 to 0.945 on a held-out real-image test set. These findings demonstrate that StyleGAN2-generated melanoma images preserve diagnostically relevant features and can provide a measurable benefit for mitigating class imbalance in melanoma-focused machine learning pipelines.